Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock

Sung Kook Chun, Jaebong Jang, Sooyoung Chung, Hwayoung Yun, Nam Jung Kim, Jong Wha Jung, Gi Hoon Son, Young Ger Suh, Kyungjin Kim

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Circadian rhythms, biological oscillations with a period of about 24 h, are maintained by a genetically determined innate time-keeping system called the molecular circadian clockwork. Despite the physiological and clinical importance of the circadian clock, the development of small molecule modulators that directly target the core clock machinery has only been recently initiated. In the present study, we aimed to identify novel small molecule modulators influencing the molecular feedback loop of the circadian clock by applying our two-step cell-based screening strategy based on E-box-mediated transcriptional activity to test more than 1000 drug-like compounds. A derivative of 2-ethoxypropanoic acid designated as compound 15 was selected as the most promising candidate in terms of both efficacy and potency. We then performed pull-down assays with the biotinylated compound and find out that both cryptochrome (CRY)1 and 2 (CRY1/2), key negative components of the mammalian circadian clock, as molecular targets of compound 15. In accordance with the binding property, compound 15 enhanced E-box-mediated transcription in a CRY1/2-dependent manner, and more importantly, it attenuated the circadian oscillation of Per2-Luc and Bmal1-dLuc activities in cultured fibroblasts, indicating that compound 15 can functionally inhibit the effects of CRY1/2 in the molecular circadian clockwork. In conclusion, the present study describes the first novel chemical inhibitor of CRY1/2 that inhibits the repressive function of CRY1/2, thereby activating CLOCK-BMAL1-evoked E-box-mediated transcription. Further optimizations and subsequent functional studies of this compound may lead to development of efficient therapeutic strategies for a variety of physiological and metabolic disorders with circadian natures.

Original languageEnglish
Pages (from-to)703-710
Number of pages8
JournalACS Chemical Biology
Volume9
Issue number3
DOIs
Publication statusPublished - 2014 Mar 21

Fingerprint

Cryptochromes
Circadian Clocks
Clocks
Transcription
Modulators
Circadian Rhythm
Lead compounds
Molecules
Fibroblasts
Machinery
Assays
Screening
Acids
Derivatives
Feedback
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Chun, S. K., Jang, J., Chung, S., Yun, H., Kim, N. J., Jung, J. W., ... Kim, K. (2014). Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. ACS Chemical Biology, 9(3), 703-710. https://doi.org/10.1021/cb400752k

Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. / Chun, Sung Kook; Jang, Jaebong; Chung, Sooyoung; Yun, Hwayoung; Kim, Nam Jung; Jung, Jong Wha; Son, Gi Hoon; Suh, Young Ger; Kim, Kyungjin.

In: ACS Chemical Biology, Vol. 9, No. 3, 21.03.2014, p. 703-710.

Research output: Contribution to journalArticle

Chun, SK, Jang, J, Chung, S, Yun, H, Kim, NJ, Jung, JW, Son, GH, Suh, YG & Kim, K 2014, 'Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock', ACS Chemical Biology, vol. 9, no. 3, pp. 703-710. https://doi.org/10.1021/cb400752k
Chun, Sung Kook ; Jang, Jaebong ; Chung, Sooyoung ; Yun, Hwayoung ; Kim, Nam Jung ; Jung, Jong Wha ; Son, Gi Hoon ; Suh, Young Ger ; Kim, Kyungjin. / Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. In: ACS Chemical Biology. 2014 ; Vol. 9, No. 3. pp. 703-710.
@article{cc1b5f0d64a24189b42af178d33e83ca,
title = "Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock",
abstract = "Circadian rhythms, biological oscillations with a period of about 24 h, are maintained by a genetically determined innate time-keeping system called the molecular circadian clockwork. Despite the physiological and clinical importance of the circadian clock, the development of small molecule modulators that directly target the core clock machinery has only been recently initiated. In the present study, we aimed to identify novel small molecule modulators influencing the molecular feedback loop of the circadian clock by applying our two-step cell-based screening strategy based on E-box-mediated transcriptional activity to test more than 1000 drug-like compounds. A derivative of 2-ethoxypropanoic acid designated as compound 15 was selected as the most promising candidate in terms of both efficacy and potency. We then performed pull-down assays with the biotinylated compound and find out that both cryptochrome (CRY)1 and 2 (CRY1/2), key negative components of the mammalian circadian clock, as molecular targets of compound 15. In accordance with the binding property, compound 15 enhanced E-box-mediated transcription in a CRY1/2-dependent manner, and more importantly, it attenuated the circadian oscillation of Per2-Luc and Bmal1-dLuc activities in cultured fibroblasts, indicating that compound 15 can functionally inhibit the effects of CRY1/2 in the molecular circadian clockwork. In conclusion, the present study describes the first novel chemical inhibitor of CRY1/2 that inhibits the repressive function of CRY1/2, thereby activating CLOCK-BMAL1-evoked E-box-mediated transcription. Further optimizations and subsequent functional studies of this compound may lead to development of efficient therapeutic strategies for a variety of physiological and metabolic disorders with circadian natures.",
author = "Chun, {Sung Kook} and Jaebong Jang and Sooyoung Chung and Hwayoung Yun and Kim, {Nam Jung} and Jung, {Jong Wha} and Son, {Gi Hoon} and Suh, {Young Ger} and Kyungjin Kim",
year = "2014",
month = "3",
day = "21",
doi = "10.1021/cb400752k",
language = "English",
volume = "9",
pages = "703--710",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock

AU - Chun, Sung Kook

AU - Jang, Jaebong

AU - Chung, Sooyoung

AU - Yun, Hwayoung

AU - Kim, Nam Jung

AU - Jung, Jong Wha

AU - Son, Gi Hoon

AU - Suh, Young Ger

AU - Kim, Kyungjin

PY - 2014/3/21

Y1 - 2014/3/21

N2 - Circadian rhythms, biological oscillations with a period of about 24 h, are maintained by a genetically determined innate time-keeping system called the molecular circadian clockwork. Despite the physiological and clinical importance of the circadian clock, the development of small molecule modulators that directly target the core clock machinery has only been recently initiated. In the present study, we aimed to identify novel small molecule modulators influencing the molecular feedback loop of the circadian clock by applying our two-step cell-based screening strategy based on E-box-mediated transcriptional activity to test more than 1000 drug-like compounds. A derivative of 2-ethoxypropanoic acid designated as compound 15 was selected as the most promising candidate in terms of both efficacy and potency. We then performed pull-down assays with the biotinylated compound and find out that both cryptochrome (CRY)1 and 2 (CRY1/2), key negative components of the mammalian circadian clock, as molecular targets of compound 15. In accordance with the binding property, compound 15 enhanced E-box-mediated transcription in a CRY1/2-dependent manner, and more importantly, it attenuated the circadian oscillation of Per2-Luc and Bmal1-dLuc activities in cultured fibroblasts, indicating that compound 15 can functionally inhibit the effects of CRY1/2 in the molecular circadian clockwork. In conclusion, the present study describes the first novel chemical inhibitor of CRY1/2 that inhibits the repressive function of CRY1/2, thereby activating CLOCK-BMAL1-evoked E-box-mediated transcription. Further optimizations and subsequent functional studies of this compound may lead to development of efficient therapeutic strategies for a variety of physiological and metabolic disorders with circadian natures.

AB - Circadian rhythms, biological oscillations with a period of about 24 h, are maintained by a genetically determined innate time-keeping system called the molecular circadian clockwork. Despite the physiological and clinical importance of the circadian clock, the development of small molecule modulators that directly target the core clock machinery has only been recently initiated. In the present study, we aimed to identify novel small molecule modulators influencing the molecular feedback loop of the circadian clock by applying our two-step cell-based screening strategy based on E-box-mediated transcriptional activity to test more than 1000 drug-like compounds. A derivative of 2-ethoxypropanoic acid designated as compound 15 was selected as the most promising candidate in terms of both efficacy and potency. We then performed pull-down assays with the biotinylated compound and find out that both cryptochrome (CRY)1 and 2 (CRY1/2), key negative components of the mammalian circadian clock, as molecular targets of compound 15. In accordance with the binding property, compound 15 enhanced E-box-mediated transcription in a CRY1/2-dependent manner, and more importantly, it attenuated the circadian oscillation of Per2-Luc and Bmal1-dLuc activities in cultured fibroblasts, indicating that compound 15 can functionally inhibit the effects of CRY1/2 in the molecular circadian clockwork. In conclusion, the present study describes the first novel chemical inhibitor of CRY1/2 that inhibits the repressive function of CRY1/2, thereby activating CLOCK-BMAL1-evoked E-box-mediated transcription. Further optimizations and subsequent functional studies of this compound may lead to development of efficient therapeutic strategies for a variety of physiological and metabolic disorders with circadian natures.

UR - http://www.scopus.com/inward/record.url?scp=84896985639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896985639&partnerID=8YFLogxK

U2 - 10.1021/cb400752k

DO - 10.1021/cb400752k

M3 - Article

C2 - 24387302

AN - SCOPUS:84896985639

VL - 9

SP - 703

EP - 710

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 3

ER -